semaglutide cause blood clots A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes and obesity, may also lower the risk of dangerous clots. The study's lead author, Dr. Rushad Patell of Beth What Is the Dark Side

Science 284:805808 Falcone E, Stellato F, Vileno B, Bouraguba M, Lebrun V, Ilbert M et al (2023) Revisiting the pro-oxidant activity of copper: interplay of ascorbate, cysteine, and glutathione

Add in local concerns about fraud and sketchy supply chains, and even folks who wanted the meds mightve backed off

PREMIUM K-BEAUTY BACKED BY EXPERTISE Developed by doctors and pharmacists with a focus on safe, effective ingredients

Successfully managing weight and glycemic control after discontinuing tirzepatide requires proactive, multifaceted strategies that address the underlying metabolic and behavioral factors contributing to obesity and diabetes